No Target Data

The consensus price target for XOMAP is $N/A, close to the current price of $25.4899 (N/A% implied move). Based on 9 analyst estimates, the stock appears fairly valued near current levels.

XOMAP has a consensus rating of "Buy" based on 9 Wall Street analysts. The rating breakdown is predominantly bullish, with 5 Buy/Strong Buy ratings. The consensus 12-month price target of $N/A implies N/A% upside from current levels.

XOMAP trades at a forward P/E of 32.4629x, representing a moderate valuation. With analysts targeting $N/A (N/A% implied move), the stock appears close to fair value.

The most bullish Wall Street analyst has a price target of $N/A for XOMAP, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. Our quantitative valuation model projects a bull case target of $21 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

XOMAP is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 5 have Buy ratings, 4 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month XOMAP stock forecast based on 9 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $16, with bear/bull scenarios of $10/$21.

Our quantitative valuation model calculates XOMAP's fair value at $16 (base case), with a bear case of $10 and bull case of $21. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 58/100.

XOMAP trades at a forward P/E ratio of 32.5x based on next-twelve-months earnings estimates compared to a trailing P/E of 17.5x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

XOMAP appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

XOMAP analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground. Our model's $10-$21 range provides an independent fundamental perspective.